XML 47 R23.htm IDEA: XBRL DOCUMENT v3.20.1
Results for the Year - Option activity (Details)
1 Months Ended 12 Months Ended
Apr. 30, 2019
EquityInstruments
$ / shares
Sep. 30, 2018
EquityInstruments
$ / shares
Nov. 30, 2017
EquityInstruments
Jun. 30, 2017
EquityInstruments
$ / shares
Mar. 31, 2017
$ / shares
Dec. 31, 2019
EquityInstruments
$ / shares
Dec. 31, 2018
EquityInstruments
$ / shares
Dec. 31, 2017
EquityInstruments
$ / shares
Dec. 31, 2015
EquityInstruments
Disclosure of terms and conditions of share-based payment arrangement [line items]                  
Exercise price per share | $ / shares $ 0.60 $ 1.40   $ 2.04 $ 2.80 $ 0.60      
Outstanding at beginning           12,980,000 14,191,000 46,895,000  
Granted 7,200 7,200   8,300,000   7,000 7,000 8,850,000  
Exercised             (706,000) (401,000)  
Expired           (89,000) (512,000)    
Forfeited               (5,749,000)  
Effect of the Amendment and the June 2017 Award Adjustment     28,800,000 6,600,000       (35,404,000)  
Outstanding at end           12,898,000 12,980,000 14,191,000  
Exercisable options           11,524,000      
Outstanding at beginning of year | $ / shares           $ 3.77 $ 3.45 $ 2.08  
Granted | $ / shares           0.60 1.40 2.08  
Exercised | $ / shares           0.12  
Forfeited | $ / shares               1.86  
Effect of the Amendment | $ / shares               1.33  
Outstanding at end of year | $ / shares           $ 3.80 $ 3.77 $ 3.45  
Weighted average remaining contractual life of equity awards           1 year 4 months 24 days 2 years 4 months 24 days 3 years 2 months 12 days  
Key Management Personnel                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                  
Outstanding at beginning           3,740,000 4,196,000 15,623,000  
Granted               4,350,000  
Exercised             (123,000)    
Expired             (333,000)    
Forfeited               (2,976,000)  
Effect of the Amendment and the June 2017 Award Adjustment               (12,801,000)  
Outstanding at end           3,740,000 3,740,000 4,196,000  
Exercisable options           3,493,000      
Employees and consultants                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                  
Exercise price per share | $ / shares           $ 2.83      
Outstanding at beginning           4,244,000 4,999,000 26,276,000  
Granted           7,000 7,000 4,500,000  
Exercised             (583,000) (401,000)  
Expired           (89,000) (179,000)    
Forfeited               (2,773,000)  
Effect of the Amendment and the June 2017 Award Adjustment               (22,603,000)  
Outstanding at end           4,162,000 4,244,000 4,999,000  
Exercisable options           4,034,000      
Nonemployee consultant                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                  
Outstanding at beginning           4,996,000 4,996,000 4,996,000  
Granted                 250,000
Outstanding at end           4,996,000 4,996,000 4,996,000  
Exercisable options           3,997,000